Literature DB >> 9855266

Extremely high levels of alkaline phosphatase in hospitalized patients.

O Maldonado1, R Demasi, Y Maldonado, M Taylor, F Troncale, R Vender.   

Abstract

We determined the diseases associated with extremely high levels of alkaline phosphatase in hospitalized patients. Computerized laboratory records of the Hospital of Saint Raphael identified all inpatients who had elevations of alkaline phosphatase above 1,000 U/l from April 1994 to September 1995. Thirty-seven inpatients with alkaline phosphatase levels above 1,000 U/l were identified. Six had bone involvement from malignancy or Paget's disease and were eliminated from further analysis, and 31 patients were included in the study. Levels of alkaline phosphatase ranged from 1,014 to 3,360 U/l. Ten patients had sepsis as the cause of the elevated alkaline phosphatase. These included gram-negative organisms, gram-positive organisms, and two patients with fungal sepsis. Seven of 10 patients with sepsis had an extremely high alkaline phosphatase level and a normal bilirubin, 3 of 10 patients with sepsis also had acquired immunodeficiency syndrome (AIDS). Eight patients had biliary obstruction, 7 with malignant obstruction and 1 with a common bile duct stone. Nine patients had AIDS. The cause of the elevated alkaline phosphatase in these included three with sepsis, three with mycobacterium avium intracellulare (MAI) infection, two with cytomegalovirus infection, and one with Dilantin toxicity. Three patients had diffuse liver metastases. Finally, four patients had benign intrahepatic disease, including one patient with liver hemangiomas, one patient with sarcoid hepatitis, one patient with lead toxicity, and one patient with drug-induced cholestasis. Extremely high elevations of alkaline phosphatase are most frequently seen in patients with sepsis, malignant obstruction, and AIDS. Patients with sepsis can have an extremely high alkaline phosphatase level and a normal bilirubin. A variety of other causes were also noted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855266     DOI: 10.1097/00004836-199812000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Clinical pharmacology of exogenously administered alkaline phosphatase.

Authors:  P Pickkers; F Snellen; P Rogiers; J Bakker; P Jorens; J Meulenbelt; H Spapen; J E Tulleken; R Lins; S Ramael; M Bulitta; J G van der Hoeven
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

2.  Possible association between serum alkaline phosphatase concentration and thoracicacute aortic dissection.

Authors:  Ming Yu; Juan Ding; Long Zhao; Xiang Huang; Ke-Zhong Ma
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Preoperative Serum Alkaline Phosphatase and Neurological Outcome of Cerebrovascular Surgery.

Authors:  Seongjoo Park; Eun-Su Choi; Hee-Won Jung; Ji-Youn Lee; Jin-Woo Park; Jae-Seung Bang; Yeong-Tae Jeon
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

4.  Serum Alkaline Phosphatase Level as a Prognostic Tool in Colorectal Cancer: A Study of 105 patients.

Authors:  M Wasif Saif; Dominik Alexander; Charles M Wicox
Journal:  J Appl Res       Date:  2005

5.  Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke.

Authors:  Pratibha S; Praveen-Kumar S; Agadi Jb
Journal:  J Clin Diagn Res       Date:  2014-08-20

6.  Alkaline Phosphatase Pathophysiology with Emphasis on the Seldom-Discussed Role of Defective Elimination in Unexplained Elevations of Serum ALP - A Case Report and Literature Review.

Authors:  Michael D Levitt; Sophie M Hapak; David G Levitt
Journal:  Clin Exp Gastroenterol       Date:  2022-03-15

7.  High serum alkaline phosphatase levels, a study in 181 Thai adult hospitalized patients.

Authors:  V Wiwanitkit
Journal:  BMC Fam Pract       Date:  2001-08-24       Impact factor: 2.497

8.  Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein.

Authors:  Setor K Kunutsor; Stephan J L Bakker; Jenny E Kootstra-Ros; Ronald T Gansevoort; John Gregson; Robin P F Dullaart
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

9.  Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India.

Authors:  A K Singh; A Pandey; M Tewari; R Kumar; A Sharma; K A Singh; H P Pandey; H S Shukla
Journal:  3 Biotech       Date:  2013-01-06       Impact factor: 2.406

10.  Significantly Elevated Liver Alkaline Phosphatase in Congestive Heart Failure.

Authors:  Leonid Shamban; Brijesh Patel; Michael Williams
Journal:  Gastroenterology Res       Date:  2014-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.